There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
Latest posts by Hippocratic Post (see all)
- Early onset dementia more common than previously reported - 26th July 2024
- Children’s Exposome Linked to Serum Metabolite Changes - 24th July 2024
- Is Melatonin the wonder drug of anti-aging? - 22nd July 2024